Results 21 to 30 of about 548 (160)
Разработка и регистрация лекарственных средств, 2019 Introduction. Multicomponent oral drugs containing salbutamol, bromhexine, ambroxol and guaifenesin have a mucolytic, expectorant and bronchodilator effect.
T. N. Komarov +7 more
doaj +1 more source
The Effect of Bromhexine and Thyme Oil on Enhancement of the Efficacy of Tilmicosin against Pasteurellosis in Broiler Chickens [PDF]
, 2020 Pasteurella multocida is one of the commensal flora of the upper respiratory tract. Under stress conditions, it may be involved as a secondary agent in various respiratory syndromes and caused high mortality as well as significant economic losses in ...
S Shaban, N. S. +5 more
core +1 more source
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial [PDF]
, 2022 A 28-day randomized open-label multicenter study was conducted to assess the efficacy of bromhexine plus standard of care (SOC) (n = 98) vs. SOC alone (n = 93) in 191 outpatients with mild-to-moderate COVID-19 in the primary health care setting ...
Soler López, Begoña +79 more
core +1 more source
Skin reactions attributed to the use of bromhexine
, 1994 Since 1972, the Netherlands Centre for Monitoring of Adverse Reactions to Drugs has received 22 reports of skin reactions attributed to use of bromhexine. The reports concerned II men and II women. The ages ranged between 5 months and 88 years.
van Riemsdijk, M M +3 more
core +2 more sources
Generalized Bullous Fixed Drug Eruption due to Bromhexine [PDF]
, 2016 We describe a patient with a generalized bullous form of Fixed Drug Eruption (FDE) induced by bromhexine, a commonly used drug for respiratory symptoms. This is a rare association and generalized bullous FDE is also very rare. We emphasize the importance
Cunha, A. P. +12 more
core +1 more source
Homology Modeling and Docking Studies of TMPRSS2 with Experimentally Known Inhibitors Camostat Mesylate, Nafamostat and Bromhexine Hydrochloride to Control SARS-Coronavirus-2 [PDF]
, 2020 The rapid outbreak of SARS-Coronavirus 2 (SARS-CoV-2) caused a serious global public health threat. The spike ‘S’ protein of SARS-CoV-2 and ACE2 of the host cell are being targeted to design and discover new drugs to control Covid-19 disease.
Kailas, Sonawane +10 more
core +4 more sources
BMC Complementary Medicine and Therapies, 2020 Background Rhinoviruses and influenza viruses cause millions of acute respiratory infections annually. Symptoms of mild acute respiratory infections are commonly treated with over-the-counter products like ambroxol, bromhexine, and N-acetyl cysteine, as ...
Christin Walther +2 more
doaj +1 more source
Percutaneous Absorption of Bromhexine in Rats.
Chemical and Pharmaceutical Bulletin, 1991 The percutaneous absorption of bromhexine (BH), an expectorant drug, through rat skin was examined in vitro and in vivo. BH in free base form penetrated better than the hydrochloride through the skin. When the in vitro penetration of BH was compared using Plastibase, macrogol and sucrose ester of fatty acid F-160 (DK-ester) formulations, the DK-ester ...
OGISO, Taro +2 more
openaire +3 more sources
4-Amino-5-{[cyclohexyl(methyl)amino]methyl}isophthalonitrile
IUCrData, 2019 The title compound, C16H20N4, was synthesized by cyanation of bromhexine. The compound crystallizes with two unique molecules in the asymmetric unit. The substituted aniline and cyclohexane rings are inclined to one another by 37.26 (6)° in one molecule ...
Muhammad Sharif +3 more
doaj +1 more source
Clinical Case Reports, Volume 14, Issue 8, August 2026.ABSTRACT In patients with moderate‐to‐severe COPD, short‐term (1‐day) preoperative respiratory optimization may be insufficient to prevent acute exacerbation after extubation. Prolonged preoperative preparation, meticulous intraoperative lung‐protective ventilation, and a post‐extubation rapid‐response protocol are essential.
Mengyue Gu +5 more
wiley +1 more source